Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
The law reflects growing interest in using existing imaging studies to identify cardiovascular disease risk without requiring additional scans, radiation exposure or costs.
New research could provide useful information for cancer registries and potentially help policymakers better evaluate screening outcomes to develop more effective guidelines.
Former SCCT president Ed Nicol, MD, knows there has been interest in the potential of automated CT exams. However, he isn't so sure they are possible at this point in time for a number of reasons.
The mobile DR market is dominated by niche x-ray vendors, with Shimadzu leading the way overall in performance rankings, according to Orem, Utah-based research firm KLAS.
Starting in late November, the University of Texas MD Anderson Cancer Center will become the exclusive provider of professional breast radiology services for five breast care centers in the Memorial Hermann Health System, according to an announcement from the two organizations.
Single-screening MRI can detect recurring breast cancer missed by ultrasound and mammography, suggests a study published in the August issue of Radiology.
Scanning with contrast-enhanced spectral mammography (CESM) can detect small breast tumors and help characterize breast tissue around microcalcifications, according to a study published in the August issue of Academic Radiology.
Combining digital breast tomosynthesis (DBT) with full field digital mammography (FFDM) cut recall rates by 35 percent and dramatically improved breast cancer detection, according to a recent study.
Attendees at the Association of Medical Imaging Management (AHRA) Meeting and Exposition this week will have the opportunity to see the latest entries to the growing line of 14x17 inch wireless flat panel detectors by Rayence, the new 1417WCC (Csl) and 1417WGC (Gadox).
WASHINGTON, D.C.—Breast cancer screening presents a legal minefield for providers, and breast density notification laws are set to add another wrinkle to the already complex situation, according to a presentation at the annual meeting of AHRA.
